ABOUT (+)-JQ-1 MECHANISM OF ACTION

Semaglutide, a glucagon like peptide-one (GLP-1) receptor agonist, is accessible as monotherapy in both subcutaneous along with oral dosage sort (very first approved oral GLP-one receptor agonist). It's been authorised to be a next line procedure choice for greater glycaemic Regulate in sort 2 diabetic issues and presently under scrutiny for anti-b